{
    "2021-12-06": [
        [
            {
                "time": "",
                "original_text": "天坛生物：目前公司所属血液制品企业拥有单采血浆站（含分站）74家(包括已获批未建)",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "血液制品",
                        "单采血浆站",
                        "74家"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物：持续开展COVID-19人免疫球蛋白有效性的相关研究",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "COVID-19",
                        "免疫球蛋白",
                        "有效性",
                        "研究"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：医保谈判落地 释放积极信号",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医保谈判",
                        "积极信号"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}